These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 8585756)

  • 1. Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.
    Lin JC; Cherng JM; Hung MS; Baltina LA; Baltina L; Kondratenko R
    Antiviral Res; 2008 Jul; 79(1):6-11. PubMed ID: 18423902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential quantification of Epstein-Barr virus DNA in a case of Epstein-Barr virus-associated hemophagocytic syndrome.
    Takahashi T; Oeda E; Sato Y; Tanizawa Y
    Int J Hematol; 2002 Oct; 76(3):290-1. PubMed ID: 12416743
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.
    Baldeweg T; Catalan J; Gazzard BG
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):34-41. PubMed ID: 9667558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.
    Lin JC; Smith MC; Pagano JS
    J Virol; 1984 Apr; 50(1):50-5. PubMed ID: 6321799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication.
    Meerbach A; HolĂ˝ A; Wutzler P; De Clercq E; Neyts J
    Antivir Chem Chemother; 1998 May; 9(3):275-82. PubMed ID: 9875407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus.
    Lin JC; Smith MC; Pagano JS
    Antimicrob Agents Chemother; 1985 Jun; 27(6):971-3. PubMed ID: 2992367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of L-dioxolane uracil nucleosides as anti-Epstein Barr virus agents.
    Lin JS; Kira T; Gullen E; Choi Y; Qu F; Chu CK; Cheng YC
    J Med Chem; 1999 Jun; 42(12):2212-7. PubMed ID: 10377226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some nucleoside analogs with anti-human immunodeficiency virus activity inhibit replication of Epstein-Barr virus.
    Mar EC; Chu CK; Lin JC
    Antiviral Res; 1995 Sep; 28(1):1-11. PubMed ID: 8585756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents.
    Chen SH
    Curr Med Chem; 2002 May; 9(9):899-912. PubMed ID: 11966452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
    Anderson KS
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infections: prospects for treatment.
    Gershburg E; Pagano JS
    J Antimicrob Chemother; 2005 Aug; 56(2):277-81. PubMed ID: 16006448
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.